Group One Trading, L.P. Mirum Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$24.63 - $32.85 $21,674 - $28,908	880 Added 136.01%	1,527 $48,000
Q2 2023 Aug 09, 2023	BUY	$23.51 - $30.09 $8,157 - $10,441	347 Added 115.67%	647 $16,000
Q1 2023 May 12, 2023	BUY	$19.19 - $24.1 $5,757 - $7,230	300 New	300 $7,000
Q2 2022 Aug 11, 2022	SELL	$18.42 - $27.5 $27,630 - $41,250	-1,500 Reduced 75.0%	500 $10,000
Q4 2021 Feb 11, 2022	SELL	$13.05 - $19.35 $39,150 - $58,050	-3,000 Reduced 60.0%	2,000 $32,000
Q3 2021 Nov 12, 2021	BUY	$13.95 - $20.18 $69,750 - $100,900	5,000 New	5,000 $100,000

192

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.73B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.